
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
New Zealand Kowhai seeds are notably rich in quinolizidine alkaloids such as cytisine, N-methylcytisine, and matrine, constituting 0.4-0.5% of their dry matter. While these compounds are of potential pharmaceutical interest, the specific mechanisms of action and established clinical uses for the whole seed are not detailed.

Reported Benefits (Provisional)
Origin & History

New Zealand Kowhai Seed (Sophora microphylla) is derived from the iconic Kowhai tree, native to the coastal and riverbank ecosystems of New Zealand's North and South Islands. Revered in Māori Rongoā medicine, these seeds are a potent source of polyphenols, flavonoids, and quinolizidine alkaloids, offering comprehensive support for immune function, detoxification, and metabolic health.
Research Narrative (Provisional)
Preliminary research on New Zealand Kowhai Seed indicates its rich phytochemical profile contributes to antioxidant, anti-inflammatory, and hepatoprotective activities. While traditional uses are well-established, further human clinical trials are needed to fully elucidate its efficacy in immune support, joint health, and metabolic regulation.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Polyphenols, flavonoids, and quinolizidine alkaloids: Potent antioxidants and anti-inflammatory compounds. - Saponins and tannins: Support detoxification and gut health. - Plant sterols and lignans: Contribute to hormonal balance and cardiovascular health. - Potassium, magnesium, iron: Essential minerals for enzymatic function and electrolyte balance. - Ellagitannins and catechins: Provide additional antioxidant and protective benefits. - Bioactive adaptogens: Support stress response and systemic balance.
Reported Mechanism (Provisional)
The primary bioactive compounds in New Zealand Kowhai seeds are quinolizidine alkaloids, including cytisine, N-methylcytisine, and matrine. While these compounds are known for various pharmacological activities, specific mechanisms of action relevant to the whole seed are not detailed in current research. Cytisine, for instance, is a known nicotinic acetylcholine receptor agonist, suggesting potential neurological effects, but its therapeutic application from the raw seed is not established.
Clinical Narrative (Provisional)
Preliminary research on New Zealand Kowhai Seed focuses on identifying its rich phytochemical profile, particularly high levels of alkaloids, which suggests potential antioxidant, anti-inflammatory, and hepatoprotective activities in *in vitro* or animal models. However, there are no established clinical uses for New Zealand Kowhai Seed, and comprehensive human clinical trials are urgently needed to elucidate its efficacy, safety, and appropriate dosing for any specific health condition. Existing studies primarily detail phytochemical composition rather than human therapeutic outcomes.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







